In chronic lymphocytic leukemia (CLL) patients, a densely mutated intergenic region with enhancer characteristics was identified, and its disruption causes reduced expression of the B-cell-specific TF gene PAX5 [12]. The gene discussed is TF; the disease is B-cell chronic lymphocytic leukemia.